BCRX logo

BioCryst Pharmaceuticals (BCRX) Debt to equity ratio

annual debt to equity:

-1.67+0.11(+6.18%)
December 31, 2024

Summary

  • As of today (June 1, 2025), BCRX annual debt to equity ratio is -1.67, with the most recent change of +0.11 (+6.18%) on December 31, 2024.
  • During the last 3 years, BCRX annual debt to equity has risen by +3.80 (+69.47%).
  • BCRX annual debt to equity is now -105.17% below its all-time high of 32.33, reached on December 31, 2016.

Performance

1-year change

+6.18%

3-year change

+69.47%

5-year change

-179.9%

15-year change

-369.35%

BCRX Debt to equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

5.25%
BCRX annual debt to equity ratio is higher than 5.25% of companies in Healthcare sector

Range

All-time high

32.33
BCRX annual debt to equity ratio is currently -105.17% below its historical high of 32.33

3-year low

-5.47

Earnings dates

Last annual earnings report date

Dec 31, 2024
BCRX previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
BCRX next annual earnings announcement has not yet been scheduled

OtherBCRXfinancial health metrics

annual current ratio

2.63
BCRX annual current ratio is 2.63

annual quick ratio

2.58
BCRX annual quick ratio is 2.58

Annual interest coverage ratio

0.12
BCRX annual interest coverage ratio is 0.12

Piotroski F-Score

3
BCRX piotroski f-score is 3

quarterly debt to equity:

-1.73-0.06(-3.59%)
March 31, 2025

Summary

  • As of today (June 1, 2025), BCRX quarterly debt to equity ratio is -1.73, with the most recent change of -0.06 (-3.59%) on March 31, 2025.
  • Over the past year, BCRX quarterly debt to equity has dropped by -0.02 (-1.17%).
  • BCRX quarterly debt to equity is now -105.35% below its all-time high of 32.33, reached on December 31, 2016.

Performance

3-month change

-3.59%

1-year change

-1.17%

3-year change

+52.99%

5-year change

-107.87%

BCRX quarterly debt to equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

5.27%
BCRX quarterly debt to equity ratio is higher than 5.27% of companies in Healthcare sector

Range

All-time high

32.33
BCRX quarterly debt to equity ratio is currently -105.35% below its historical high of 32.33

3-year low

-3.68

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
BCRX previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 5, 2025
BCRX next earnings announcement is scheduled for Aug 5, 2025

OtherBCRXfinancial health metrics

quarterly current ratio

2.93
BCRX quarterly current ratio is 2.93

quarterly quick ratio

2.88
BCRX quarterly quick ratio is 2.88

quarterly interest coverage ratio

1.03
BCRX quarterly interest coverage ratio is 1.03

Piotroski F-Score

3
BCRX piotroski f-score is 3

Debt to equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

annual debt to equity

-1.67
BCRX annual debt to equity ratio is -1.67

Annual Total Debt

$808.74M
BCRX annual total debt is $808.74 million

annual shareholders equity

-$475.93M
BCRX annual stockholders equity is -$475.93 million

BCRX Debt to equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.2%-1.2%
3 y3 years+69.5%+53.0%
5 y5 years-179.9%-107.9%

BCRX Debt to equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+69.5%-154.4%+53.0%
5 y5-year-179.9%+88.3%-107.9%+87.9%
alltimeall time-105.2%+97.5%-105.3%+97.4%

BCRX Debt to equity History

DateAnnualQuarterly
Mar 2025
-
-1.73(+3.6%)
Dec 2024
-1.67(-6.2%)
-1.67(-1.8%)
Sep 2024
-
-1.70(0.0%)
Jun 2024
-
-1.70(-0.6%)
Mar 2024
-
-1.71(-3.9%)
Dec 2023
-1.78(-28.5%)
-1.78(-12.3%)
Sep 2023
-
-2.03(-3.8%)
Jun 2023
-
-2.11(-7.5%)
Mar 2023
-
-2.28(-8.4%)
Dec 2022
-2.49(-54.5%)
-2.49(-15.3%)
Sep 2022
-
-2.94(+332.4%)
Jun 2022
-
-0.68(-81.5%)
Mar 2022
-
-3.68(-32.7%)
Dec 2021
-5.47(-61.6%)
-5.47(+397.3%)
Sep 2021
-
-1.10(-25.7%)
Jun 2021
-
-1.48(-27.5%)
Mar 2021
-
-2.04(-85.7%)
Dec 2020
-14.25(-781.8%)
-14.25(-730.5%)
Sep 2020
-
2.26(+115.2%)
Jun 2020
-
1.05(-95.2%)
Mar 2020
-
21.99(+952.2%)
Dec 2019
2.09(+74.2%)
2.09(-208.3%)
Sep 2019
-
-1.93(-77.6%)
Jun 2019
-
-8.61(-346.0%)
Mar 2019
-
3.50(+191.7%)
Dec 2018
1.20(+93.5%)
1.20(+48.1%)
Sep 2018
-
0.81(-23.6%)
Jun 2018
-
1.06(+30.9%)
Mar 2018
-
0.81(+30.6%)
Dec 2017
0.62(-98.1%)
0.62(+21.6%)
Sep 2017
-
0.51(-76.2%)
Jun 2017
-
2.14(+60.9%)
Mar 2017
-
1.33(-95.9%)
Dec 2016
32.33(+5474.1%)
32.33(+154.2%)
Sep 2016
-
12.72(+508.6%)
Jun 2016
-
2.09(+109.0%)
Mar 2016
-
1.00(+72.4%)
Dec 2015
0.58(+45.0%)
0.58(+23.4%)
Sep 2015
-
0.47(+20.5%)
Jun 2015
-
0.39(-17.0%)
Mar 2015
-
0.47(+17.5%)
Dec 2014
0.40(-101.5%)
0.40(+11.1%)
Sep 2014
-
0.36(+9.1%)
Jun 2014
-
0.33(-106.3%)
Mar 2014
-
-5.24(-80.3%)
Dec 2013
-26.64(-59.7%)
-26.64(-402.7%)
Sep 2013
-
8.80(-365.1%)
Jun 2013
-
-3.32(-68.6%)
Mar 2013
-
-10.56(-84.0%)
Dec 2012
-66.08(-3355.2%)
-66.08(-2252.4%)
Sep 2012
-
3.07(+59.9%)
Jun 2012
-
1.92(+47.7%)
Mar 2012
-
1.30(-36.0%)
Dec 2011
2.03(>+9900.0%)
2.03(+76.5%)
Sep 2011
-
1.15(+51.3%)
Jun 2011
-
0.76(+38.2%)
Mar 2011
-
0.55(>+9900.0%)
Dec 2010
0.00(0.0%)
0.00(0.0%)
Sep 2010
-
0.00(0.0%)
Jun 2010
-
0.00(0.0%)
Mar 2010
-
0.00(0.0%)
Dec 2009
0.00
0.00(0.0%)
DateAnnualQuarterly
Sep 2009
-
0.00(0.0%)
Jun 2009
-
0.00(0.0%)
Mar 2009
-
0.00(0.0%)
Dec 2008
0.00(0.0%)
0.00(0.0%)
Sep 2008
-
0.00(0.0%)
Jun 2008
-
0.00(0.0%)
Mar 2008
-
0.00(0.0%)
Dec 2007
0.00(0.0%)
0.00(0.0%)
Sep 2007
-
0.00(0.0%)
Jun 2007
-
0.00(0.0%)
Mar 2007
-
0.00(0.0%)
Dec 2006
0.00(0.0%)
0.00(0.0%)
Sep 2006
-
0.00(0.0%)
Jun 2006
-
0.00(0.0%)
Mar 2006
-
0.00(0.0%)
Dec 2005
0.00(0.0%)
0.00(0.0%)
Sep 2005
-
0.00(0.0%)
Jun 2005
-
0.00(0.0%)
Mar 2005
-
0.00(0.0%)
Dec 2004
0.00(0.0%)
0.00(0.0%)
Sep 2004
-
0.00(0.0%)
Jun 2004
-
0.00(0.0%)
Mar 2004
-
0.00(0.0%)
Dec 2003
0.00(0.0%)
0.00(0.0%)
Sep 2003
-
0.00(0.0%)
Jun 2003
-
0.00(0.0%)
Mar 2003
-
0.00(0.0%)
Dec 2002
0.00(0.0%)
0.00(0.0%)
Sep 2002
-
0.00(0.0%)
Jun 2002
-
0.00(0.0%)
Mar 2002
-
0.00(0.0%)
Dec 2001
0.00(0.0%)
0.00(0.0%)
Sep 2001
-
0.00(0.0%)
Jun 2001
-
0.00(0.0%)
Mar 2001
-
0.00(0.0%)
Dec 2000
0.00(0.0%)
0.00(0.0%)
Sep 2000
-
0.00(0.0%)
Jun 2000
-
0.00(0.0%)
Mar 2000
-
0.00(0.0%)
Dec 1999
0.00(0.0%)
0.00(0.0%)
Sep 1999
-
0.00(0.0%)
Jun 1999
-
0.00(0.0%)
Mar 1999
-
0.00(0.0%)
Dec 1998
0.00(0.0%)
0.00(0.0%)
Sep 1998
-
0.00(0.0%)
Jun 1998
-
0.00(0.0%)
Mar 1998
-
0.00(0.0%)
Dec 1997
0.00(-100.0%)
0.00(0.0%)
Sep 1997
-
0.00(-100.0%)
Jun 1997
-
0.01(0.0%)
Mar 1997
-
0.01(0.0%)
Dec 1996
0.01(-80.0%)
0.01(0.0%)
Sep 1996
-
0.01(-50.0%)
Jun 1996
-
0.02(-33.3%)
Mar 1996
-
0.03(-40.0%)
Dec 1995
0.05(-37.5%)
0.05(0.0%)
Sep 1995
-
0.05(+25.0%)
Jun 1995
-
0.04(-50.0%)
Mar 1995
-
0.08(0.0%)
Dec 1994
0.08
0.08(+14.3%)
Sep 1994
-
0.07(-22.2%)
Jun 1994
-
0.09(+12.5%)
Mar 1994
-
0.08

FAQ

  • What is BioCryst Pharmaceuticals annual debt to equity ratio?
  • What is the all time high annual debt to equity for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual debt to equity year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly debt to equity year-on-year change?

What is BioCryst Pharmaceuticals annual debt to equity ratio?

The current annual debt to equity of BCRX is -1.67

What is the all time high annual debt to equity for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual debt to equity ratio is 32.33

What is BioCryst Pharmaceuticals annual debt to equity year-on-year change?

Over the past year, BCRX annual debt to equity ratio has changed by +0.11 (+6.18%)

What is BioCryst Pharmaceuticals quarterly debt to equity ratio?

The current quarterly debt to equity of BCRX is -1.73

What is the all time high quarterly debt to equity for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly debt to equity ratio is 32.33

What is BioCryst Pharmaceuticals quarterly debt to equity year-on-year change?

Over the past year, BCRX quarterly debt to equity ratio has changed by -0.02 (-1.17%)
On this page